Published in Virology on April 25, 1999
An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol (2000) 4.00
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep (2003) 3.29
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
The global distribution of yellow fever and dengue. Adv Parasitol (2006) 2.76
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis (2010) 2.17
Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis (2002) 2.03
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog (2007) 1.97
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92
An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol (2004) 1.81
Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest (2005) 1.76
Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc Biol Sci (2009) 1.75
Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J Clin Microbiol (2002) 1.71
Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol (2003) 1.65
Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol (2003) 1.55
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54
Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol (2007) 1.52
Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells. PLoS One (2011) 1.52
Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol (2009) 1.43
Dengue viruses - an overview. Infect Ecol Epidemiol (2013) 1.40
Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infect Dis (2004) 1.35
Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003). PLoS Negl Trop Dis (2012) 1.32
Dengue 1 diversity and microevolution, French Polynesia 2001-2006: connection with epidemiology and clinics. PLoS Negl Trop Dis (2009) 1.32
Impact of renal failure on the outcome of dengue viral infection. Clin J Am Soc Nephrol (2008) 1.28
Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol (2005) 1.26
Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25
High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. PLoS One (2007) 1.25
Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol (2007) 1.24
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Lett (2007) 1.21
Association of mast cell-derived VEGF and proteases in Dengue shock syndrome. PLoS Negl Trop Dis (2012) 1.15
Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol (2000) 1.13
Viral and epidemiological determinants of the invasion dynamics of novel dengue genotypes. PLoS Negl Trop Dis (2010) 1.12
Dengue virus selectively induces human mast cell chemokine production. J Virol (2002) 1.12
Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol (2007) 1.11
Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J Virol (2005) 1.11
Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine (2008) 1.11
Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol (2008) 1.09
Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo. J Med Virol (2009) 1.08
Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis (2011) 1.08
Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin Vaccine Immunol (2007) 1.06
TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis (2009) 1.06
Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators. Mediators Inflamm (2015) 1.05
Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production. BMC Infect Dis (2010) 1.04
Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens. Clin Vaccine Immunol (2007) 1.04
Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection. BMC Infect Dis (2005) 1.03
Estimation of dengue virus IgM persistence using regression analysis. Clin Vaccine Immunol (2011) 1.00
Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection [corrected]. PLoS Negl Trop Dis (2014) 0.99
Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J Virol (2001) 0.99
The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One (2014) 0.95
Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset. Clin Vaccine Immunol (2011) 0.95
Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells. Am J Trop Med Hyg (2012) 0.93
Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Virol J (2012) 0.92
Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. J Virol (2000) 0.92
Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One (2010) 0.92
Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. J Virol (2011) 0.91
A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection. Am J Pathol (2011) 0.91
Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. J Infect Dis (2009) 0.90
Dengue virus type 2 modulates endothelial barrier function through CD73. Am J Trop Med Hyg (2012) 0.89
Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS One (2012) 0.88
Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function. J Gen Virol (2009) 0.86
Dermal CD14(+) Dendritic Cell and Macrophage Infection by Dengue Virus Is Stimulated by Interleukin-4. J Invest Dermatol (2014) 0.86
Mast cells and influenza a virus: association with allergic responses and beyond. Front Immunol (2015) 0.85
Virus antibody dynamics in primary and secondary dengue infections. J Math Biol (2014) 0.84
Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus. Virology (2013) 0.84
Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia. Ann Trop Med Parasitol (2010) 0.84
Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands. Clin Vaccine Immunol (2011) 0.83
Pathogenesis of Dengue: Dawn of a New Era. F1000Res (2015) 0.82
Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication. Virus Res (2011) 0.81
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection. Mediators Inflamm (2015) 0.81
Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes. PLoS Negl Trop Dis (2016) 0.81
Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1. PLoS Negl Trop Dis (2012) 0.80
The usefulness of clinical-practice-based laboratory data in facilitating the diagnosis of dengue illness. Biomed Res Int (2013) 0.79
Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients. J Trop Med (2014) 0.78
Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development. Immunology (2015) 0.78
Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques. Immunogenetics (2011) 0.78
Deadly intracranial bleed in patients with dengue fever: A series of nine patients and review of literature. J Neurosci Rural Pract (2016) 0.78
Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection. PLoS One (2014) 0.77
Incidence and Predictive Factors of Central Nervous System Dysfunction in Patients Consulting for Dengue Fever in Cayenne Hospital, French Guiana. PLoS One (2016) 0.77
Fibrin formation and lysis studies in dengue virus infection. Blood Coagul Fibrinolysis (2009) 0.76
Significance of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in susceptibility to dengue viral infection. J Clin Immunol (2008) 0.76
Dengue Virus Directly Stimulates Polyclonal B Cell Activation. PLoS One (2015) 0.76
Retrospective analysis of prognostic factors in dengue infected patients with intracranial bleed. Surg Neurol Int (2016) 0.75
The Pattern of Adipose Tissue Accumulation during Early Infancy Provides an Environment for the Development of Dengue Hemorrhagic Fever. PLoS Negl Trop Dis (2015) 0.75
Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response. Clin Exp Immunol (2015) 0.75
Normal free interleukin-18 (IL-18) plasma levels in dengue virus infection and the need to measure both total IL-18 and IL-18 binding protein levels. Clin Vaccine Immunol (2015) 0.75
Peripheral Organs of Dengue Fatal Cases Present Strong Pro-Inflammatory Response with Participation of IFN-Gamma-, TNF-Alpha- and RANTES-Producing Cells. PLoS One (2016) 0.75
Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections. Cell Host Microbe (2017) 0.75
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13
Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (1988) 3.44
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96
Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr (1977) 2.66
A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis (1977) 2.55
Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol (1999) 2.54
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J Virol (1996) 2.35
Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol (1981) 2.19
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol (1998) 2.10
Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J Immunol (1981) 2.04
High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis (1999) 2.02
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92
Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature (1978) 1.89
Influenza virus infection in nude mice. J Infect Dis (1976) 1.85
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79
Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis (1983) 1.79
Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75
Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol (1988) 1.71
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68
Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody. Infect Immun (1973) 1.67
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64
A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J Virol (1992) 1.63
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61
The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol (1978) 1.60
Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand (1980) 1.59
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol (1989) 1.55
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol (1991) 1.52
Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child (1979) 1.51
Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol (1991) 1.50
Impaired T cell proliferation in acute dengue infection. J Immunol (1999) 1.46
Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol (1992) 1.46
Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect Immun (1980) 1.43
Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J Infect Dis (1973) 1.39
Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J Exp Med (1985) 1.37
Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest (1996) 1.35
Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity. Am J Dis Child (1968) 1.34
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol (1995) 1.32
Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol (1998) 1.31
Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol (1999) 1.29
HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet (1981) 1.28
Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J Virol (1996) 1.28
Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol (1990) 1.27
Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. Proc Natl Acad Sci U S A (1991) 1.26
Sensitive neutralization test for virus antibody. 1. Mumps antibody. Arch Virol (1978) 1.25
Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia. J Exp Med (1978) 1.25
Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique. J Gen Virol (1979) 1.24
Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J Gen Virol (1986) 1.24
Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol (2001) 1.24
High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis (1999) 1.24
Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans. J Virol (1993) 1.23
Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus. J Virol (1996) 1.22
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature (1978) 1.20
Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J Virol (1989) 1.20
Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun (1978) 1.19
Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis (1977) 1.16
Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol (1992) 1.16
Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health (1990) 1.15
HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol (1988) 1.14
Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J Gen Virol (1986) 1.14
Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. J Virol (1992) 1.13
Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine. J Infect Dis (1994) 1.13
Influenza immunization policies and practices in Japan. J Infect Dis (1980) 1.12
The elimination of herpes simplex plaques by antibody and the emergence of resistant strains. J Immunol (1977) 1.11
IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. J Immunol (1999) 1.11
Subacute sclerosing panencephalitis: experimental infection in primates. Science (1977) 1.10
Immunologic responses to vaccinia vaccines administered by different parenteral routes. J Infect Dis (1997) 1.09
Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine. Nature (1977) 1.09
Review of existing vaccines for influenza. Am J Clin Pathol (1978) 1.09
Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J Immunol (1999) 1.08
Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J Virol (1990) 1.08
Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol (1988) 1.08
Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone. Mol Immunol (1991) 1.08
Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone. J Virol (1993) 1.08
Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4. Virology (1998) 1.08
Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli. J Exp Med (1985) 1.08
A plaque neutralization test for determining mumps antibodies. Proc Soc Exp Biol Med (1968) 1.08
Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Virology (1990) 1.07
Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J Virol (1999) 1.07
Influenza vaccine in unprimed children: improved immunogenicity with few reactions following one high dose of split-product vaccine. J Pediatr (1980) 1.07
Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. J Virol (1993) 1.07
New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion. J Biol Stand (1980) 1.06
Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology (1991) 1.06
Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol (1999) 1.05